Chris Collins, Cfa
About Chris Collins, Cfa
Highly experienced biotech adviser/investor. Over 20 years of advising high profile biotech companies (Moderna, CRISPR etc.). Rare perspective resulting from experience as investor, banker and operator. Unique expertise that spans the entire life span of a biotech company, from company formation to IPO to acquisition. Strong Wall Street sellside and buyside network spanning many top tier institutions. Blue chip education (Stanford undergrad, Johns Hopkins Masters, CFA). Select clients that have been acquired: Array, Alpine Immune, Ambit, Amylin, ChemoCentryx, Cymabay, Deciphera, Harpoon, Human Genome Sciences, Ignyta, Medivation, Mirati, Oyster Point, Reata, Tesaro and VectivBio Wells Fargo Corporate & Investment Banking is the trade name for the corporate banking, capital markets and investment banking services of Wells Fargo & Company and its subsidiaries. These services are offered to institutional customers. Not all financial products offered under this trade name are securities, and unless otherwise expressly stated, financial products are not bank deposits or FDIC insured. Many of these subsidiaries are distinct entities from affiliated banks and thrifts. This communication will be retained by Wells Fargo & Company and its subsidiaries inline with the privacy policy. Please cut and paste the following links into your browser and navigate to important disclosure information: https://www.wellsfargo.com/com/disclaimer/ged5; and important data privacy information: www.wellsfargo.com/com/privacy-security